Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GENETRON HOLDINGS LIMITED

(GTH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
14.99(c) 13(c) 14.24(c) 14.69(c) 14.2(c) Last
556 633 737 629 507 614 448 466 491 182 Volume
-19.15% -13.28% +9.54% +3.16% -3.34% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 96,4 M - -
Net income 2021 -50,8 M - -
Net Debt 2021 - - -
P/E ratio 2021 -128x
Yield 2021 -
Sales 2022 144 M - -
Net income 2022 -26,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 -81,8x
Yield 2022 -
Capitalization 1 262 M 1 262 M -
Capi. / Sales 2021 13,1x
Capi. / Sales 2022 8,75x
Nbr of Employees 799
Free-Float 84,0%
More Financials
Company
Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous... 
More about the company
Ratings of Genetron Holdings Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about GENETRON HOLDINGS LIMITED
07/29Genetron Health Partners with Guizhou Province's Dafang County to Lead Liver ..
GL
07/29Genetron Holdings Limited Partners with Guizhou Province’s Dafang County to L..
CI
07/26GENETRON : Says CDx Diagnostic Test Kit Now Under Priority Review, Approval Proc..
MT
07/26GENETRON : AYVAKIT® (avapritinib) Companion Diagnostic Test Enters Priority Revi..
AQ
07/13GENETRON : Obtains CE Mark for 8-Gene Lung Cancer Assay
MT
07/13GENETRON : Health Receives CE Mark for 8-Gene Lung Cancer Assay and Provides FDA..
AQ
07/13Genetron Health Limited Receives CE Mark for 8-Gene Lung Cancer Assay and Pro..
CI
07/01Genetron Health Enters into Platform Partnership with World Economic Forum
GL
07/01Genetron Health Enters into Platform Partnership with World Economic Forum
CI
06/30GENETRON : Health Announces Changes to the Board of Directors and Executive Offi..
PU
06/30Genetron Holdings Limited Announces Board Changes
CI
06/04Genetron Health Releases 16 New Research Results at 2021 American Society of ..
GL
05/24GENETRON : Health Reports First Quarter 2021 Unaudited Financial Results (Form 6..
PU
05/24GENETRON : 1Q21 Presentation
PU
05/24GENETRON : Posts Higher Q1 Revenue, Maintains 2021 Revenue Outlook
MT
More news
News in other languages on GENETRON HOLDINGS LIMITED

- No features available -

More news
Chart GENETRON HOLDINGS LIMITED
Duration : Period :
Genetron Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENETRON HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 14,20 $
Average target price 24,96 $
Spread / Average Target 75,8%
EPS Revisions
Managers and Directors
Si Zhen Wang Chief Executive Officer & Director
Ce Xu Chief Financial Officer
Wei-Wu He Chairman
Hai Yan Chief Scientific Officer & Director
Yu Chen Jiao Chief Technology Officer & Director